NRX Pharmaceuticals Inc

INDEX

CAUTIONARY STATEMENT

This document and the information incorporated by reference herein include “forward-looking statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, whichmay include, but are not limitedto, statements regarding our financial outlook, product development, business prospects, and market and industry trends and conditions, as well as the Company’sstrategies, plans, objectives, andgoals. These forward-looking statements are based on current beliefs, expectations, estimates, forecasts, and projections of, as well as assumptions made by, and information currently availableto, the Company’smanagement. Words such as “expect,”“anticipate,”“should,”“believe,” “hope,”“target,” “project,”“goals,”“estimate,”“potential,” “predict,”“may,”“will,” “might,” “could,”“would,”“seek,” “plan,” “intend,”“shall,”and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. These forward- looking statementsare, by their nature, subject to significant risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’scontrol. These risks and uncertainties include, but are not limitedto, ourrelatively limited operating history; our ability to expand, retain and motivate our employees and manage our growth; risks associated with general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the Company’sability to accurately predict future market conditions; manufacturing difficulties or delays; changes inlaws, rules or regulations relating toany aspect of the Company’sbusiness operations, or general economic, market and business conditions; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Company’spatents and other protectionsfor innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. Furthermore, there can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvalsor that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual resultsmay differ materially from those set forth in the forward-looking statements. The Company assumes no obligation and does not intend to update or otherwise reviseany forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicablelaw. As a result of these and other risks, uncertainties and assumptions, forward-looking events and circumstances discussed herein might not occur in the way that the Company’s management expects, if at all. Accordingly, youshould not place reliance onany forward-looking statement, andall forward-looking statements are herein qualified by reference to the cautionary statements set forth above.